Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|December 1, 2005
- Volume 0 0
Exacta-Med Oral Dispenser
Advertisement
Baxa Corporation's (Englewood, Colo) Exacta-Med Oral Dispenser is specifically designed for safe oral liquid delivery. The product's design prevents the attachment of a luer needle hub and from engaging with a needleless connector, eliminating potential error from wrongroute oral liquid medication administration. The Exacta-Med Oral Dispenser also is labeled "Oral Use Only," further promoting patient safety. For more information, visit
Articles in this issue
almost 21 years ago
CAN YOU READ THESE Rxs?almost 21 years ago
Bar Coding Thwarts Illegitimate Drug Usealmost 21 years ago
COMPREHENSIVE CARE CLINIC: DIABETES: Diabetes-related Stress and Depressionalmost 21 years ago
Hypertension Counseling Requires a Multifactorial Approachalmost 21 years ago
COMPOUNDING HOTLINEalmost 21 years ago
Pharmacy Law: Duty to Warn Waived When Patient Refuses Counselingalmost 21 years ago
EnterpriseRx Pharmacy Management Systemalmost 21 years ago
Hospital Installs Automated Medication Cabinetsalmost 21 years ago
"Smartphones" Help with Clinical Trial Informationalmost 21 years ago
HIT Needs Medicare's LeadershipAdvertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
4
Tec-Dara Cuts Death Risk 78% Without Raising Fatal Toxicity
5